- Home
- CNXN vs BCRX Comparison
CNXN vs BCRX Comparison
Compare CNXN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNXN | BCRX |
|---|---|---|
| Founded | 1982 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 1998 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CNXN | BCRX |
|---|---|---|
| Price | $59.31 | $7.44 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $20.08 |
| AVG Volume (30 Days) | 83.9K | ★ 4.0M |
| Earning Date | 02-04-2026 | 11-03-2025 |
| Dividend Yield | ★ 0.99% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $2,878,704,000.00 | $599,816,000.00 |
| Revenue This Year | $5.85 | $40.20 |
| Revenue Next Year | $4.52 | $7.71 |
| P/E Ratio | $18.65 | ★ N/A |
| Revenue Growth | 3.19 | ★ 45.38 |
| 52 Week Low | $54.97 | $6.00 |
| 52 Week High | $74.99 | $11.31 |
Technical Indicators
Market Signals| Indicator | CNXN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 54.69 |
| Support Level | $58.95 | $7.11 |
| Resistance Level | $61.50 | $7.92 |
| Average True Range (ATR) | 1.35 | 0.38 |
| MACD | 0.17 | -0.02 |
| Stochastic Oscillator | 33.68 | 40.09 |
Price Performance
Historical ComparisonAbout CNXN PC Connection Inc.
PC Connection Inc is a provider of information technology solutions. It provides products such as computer systems, software and peripheral equipment, networking communications, and other products and accessories that company purchase from manufacturers and distributors. The company also offers services involving design, configuration, and implementation of IT solutions. It conducts business operations through three business segments namely Connection Business Solutions, Connection Enterprise Solutions, and Connection Public Sector Solutions. The company generates maximum revenue Connection Enterprise Solutions segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.